Healthcare Sector Stocks
The Healthcare sector has a total of 1059 stocks, with a combined market cap of $9.51 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 50.98.
Market Cap
9.51T
Revenue
4.66T
Profits
186.47B
PE Ratio
50.98
Profit Margin
4.00%
Dividend Yield
0.37%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.11T | -2.81% | 2,621,395 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 644.33B | -2.21% | 6,475,879 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 462.68B | -1.56% | 5,228,693 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 367.58B | -2.11% | 16,442,165 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 345.44B | -0.97% | 4,497,175 | 450.53B |
| 6 | NVS | Novartis AG | 300.60B | -2.54% | 1,525,743 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 255.77B | -0.28% | 5,094,199 | 61.37B |
| 8 | AMGN | Amgen Inc. | 234.49B | -1.95% | 2,914,113 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 232.03B | 2.28% | 2,750,082 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 204.73B | -0.73% | 9,669,184 | 50.34B |
| 11 | ABT | Abbott Laboratories | 197.51B | -0.25% | 5,785,014 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 177.86B | -2.82% | 7,167,580 | 30.46B |
| 13 | PFE | Pfizer Inc. | 158.39B | -1.59% | 29,297,032 | 63.70B |
| 14 | DHR | Danaher Corporation | 151.78B | 2.09% | 5,503,177 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 136.93B | -2.14% | 1,062,327 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 133.74B | -3.17% | 9,489,634 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 132.30B | -5.84% | 3,970,861 | 11.03B |
| 18 | SYK | Stryker Corporation | 125.70B | -3.61% | 2,233,507 | 25.84B |
| 19 | CVS | CVS Health Corporation | 119.78B | - | 6,439,573 | 412.65B |
| 20 | MDT | Medtronic plc | 118.14B | -1.94% | 6,348,837 | 36.36B |
| 21 | SNY | Sanofi | 108.85B | -1.48% | 2,478,291 | 55.89B |
| 22 | GSK | GSK plc | 104.98B | -1.74% | 3,598,464 | 44.05B |
| 23 | MCK | McKesson Corporation | 97.79B | -1.75% | 557,621 | 410.98B |
| 24 | HCA | HCA Healthcare, Inc. | 87.96B | -0.19% | 1,063,638 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 85.94B | -0.54% | 812,918 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 82.54B | -1.69% | 596,475 | 15.53B |
| 27 | CI | The Cigna Group | 72.51B | -1.10% | 1,088,679 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 71.55B | -5.08% | 20,390,203 | 21.00B |
| 29 | ARGX | argenx SE | 64.66B | 0.51% | 258,298 | 5.32B |
| 30 | COR | Cencora, Inc. | 60.05B | -0.76% | 1,175,755 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 58.59B | -1.15% | 2,225,254 | 28.42B |
| 32 | MRNA | Moderna, Inc. | 53.23B | -23.55% | 99,500,560 | 2.23B |
| 33 | CAH | Cardinal Health, Inc. | 53.13B | -2.72% | 1,592,907 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 51.78B | -2.65% | 2,638,019 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 51.11B | 0.01% | 1,972,639 | 22.48B |
| 36 | NTRA | Natera, Inc. | 46.82B | -0.07% | 1,738,169 | 2.71B |
| 37 | HUM | Humana Inc. | 45.72B | 0.72% | 1,316,615 | 145.68B |
| 38 | RVMD | Revolution Medicines, Inc. | 45.38B | -1.36% | 1,563,572 | - |
| 39 | A | Agilent Technologies, Inc. | 44.14B | 0.57% | 2,830,004 | 7.23B |
| 40 | HLN | Haleon plc | 43.25B | - | 8,078,454 | 14.80B |
| 41 | IDXX | IDEXX Laboratories, Inc. | 43.00B | -2.91% | 610,648 | 4.55B |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 42.89B | -1.76% | 4,513,311 | 17.32B |
| 43 | MDLN | Medline Inc. | 42.83B | -3.92% | 6,768,185 | 29.94B |
| 44 | IQV | IQVIA Holdings Inc. | 42.15B | 2.72% | 1,787,421 | 16.98B |
| 45 | ONC | BeOne Medicines AG | 41.97B | -2.04% | 215,491 | 6.13B |
| 46 | VEEV | Veeva Systems Inc. | 40.70B | -0.19% | 1,305,707 | 3.32B |
| 47 | WAT | Waters Corporation | 39.76B | -2.68% | 1,233,799 | 4.64B |
| 48 | ALC | Alcon Inc. | 35.87B | -1.79% | 1,503,798 | 10.86B |
| 49 | RPRX | Royalty Pharma plc | 34.83B | -1.86% | 2,458,340 | 2.54B |
| 50 | DXCM | DexCom, Inc. | 34.05B | 0.38% | 5,155,536 | 4.97B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 33.45B | -0.75% | 2,499,549 | 21.27B |
| 52 | RMD | ResMed Inc. | 32.95B | -0.67% | 1,285,592 | 5.65B |
| 53 | ILMN | Illumina, Inc. | 32.20B | 4.02% | 2,859,623 | 4.49B |
| 54 | CNC | Centene Corporation | 31.68B | -0.87% | 3,267,665 | 180.30B |
| 55 | BIIB | Biogen Inc. | 31.67B | -3.25% | 808,626 | 10.03B |
| 56 | ZTS | Zoetis Inc. | 31.00B | -2.16% | 3,917,159 | 9.53B |
| 57 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.68B | -5.49% | 1,701,686 | 4.80B |
| 58 | MTD | Mettler-Toledo International Inc. | 27.92B | -2.24% | 444,596 | 4.13B |
| 59 | BNTX | BioNTech SE | 27.86B | -1.97% | 3,534,287 | 3.03B |
| 60 | INSM | Insmed Incorporated | 27.32B | -4.27% | 1,761,851 | 1.14B |
| 61 | PHG | Koninklijke Philips N.V. | 27.09B | -0.43% | 586,712 | 20.18B |
| 62 | LH | Labcorp Holdings Inc. | 26.99B | 0.72% | 731,838 | 14.35B |
| 63 | DGX | Quest Diagnostics Incorporated | 26.63B | -0.19% | 1,139,385 | 11.56B |
| 64 | ROIV | Roivant Sciences Ltd. | 26.61B | -1.50% | 3,127,813 | 7.53M |
| 65 | INCY | Incyte Corporation | 25.79B | -0.97% | 1,207,144 | 5.82B |
| 66 | WST | West Pharmaceutical Services, Inc. | 24.90B | 0.28% | 588,383 | 3.33B |
| 67 | STE | STERIS plc | 22.98B | -0.49% | 565,424 | 6.04B |
| 68 | GH | Guardant Health, Inc. | 22.53B | 2.78% | 2,549,234 | 1.18B |
| 69 | UTHR | United Therapeutics Corporation | 22.35B | -1.54% | 440,382 | 3.15B |
| 70 | THC | Tenet Healthcare Corporation | 21.95B | 1.52% | 616,642 | 21.81B |
| 71 | GMAB | Genmab A/S | 19.98B | -2.05% | 6,189,844 | 4.13B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 18.88B | -1.76% | 1,333,532 | 8.51B |
| 73 | VTRS | Viatris Inc. | 18.52B | -0.80% | 5,329,440 | 14.74B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.10B | 0.72% | 254,525 | 2.78B |
| 75 | ASND | Ascendis Pharma A/S | 16.73B | -1.85% | 475,038 | 1.20B |
| 76 | BBIO | BridgeBio Pharma, Inc. | 16.21B | -1.20% | 1,694,086 | 713.07M |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 16.14B | -1.37% | 439,915 | 4.60B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 15.55B | -1.68% | 870,659 | 3.37B |
| 79 | SOLV | Solventum Corporation | 15.08B | 0.91% | 805,056 | 8.31B |
| 80 | COO | The Cooper Companies, Inc. | 14.85B | -0.74% | 1,079,076 | 4.23B |
| 81 | CRL | Charles River Laboratories International, Inc. | 13.91B | 0.50% | 1,059,341 | 4.00B |
| 82 | RVTY | Revvity, Inc. | 13.85B | 3.92% | 2,344,488 | 2.91B |
| 83 | BAX | Baxter International Inc. | 13.65B | -0.86% | 3,527,895 | 11.47B |
| 84 | ICLR | ICON Public Limited Company | 13.45B | 1.03% | 432,380 | 8.29B |
| 85 | EXEL | Exelixis, Inc. | 13.30B | -1.29% | 1,944,154 | 2.44B |
| 86 | BMRN | BioMarin Pharmaceutical Inc. | 13.10B | -2.38% | 1,275,619 | 3.41B |
| 87 | CORT | Corcept Therapeutics Incorporated | 13.09B | 1.71% | 785,026 | 830.81M |
| 88 | PEN | Penumbra, Inc. | 12.75B | -0.94% | 210,042 | 1.50B |
| 89 | FMS | Fresenius Medical Care AG | 12.66B | -1.72% | 787,069 | 22.19B |
| 90 | BTSG | BrightSpring Health Services, Inc. | 12.40B | 0.34% | 1,477,366 | 14.37B |
| 91 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.36B | -2.17% | 896,882 | 669.50M |
| 92 | SNN | Smith & Nephew plc | 12.32B | -0.92% | 1,239,857 | 6.30B |
| 93 | HALO | Halozyme Therapeutics, Inc. | 12.04B | -1.39% | 1,577,467 | 1.66B |
| 94 | TEM | Tempus AI, Inc. | 12.03B | 8.82% | 20,144,360 | 1.43B |
| 95 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.99B | -3.90% | 264,418 | 1.28B |
| 96 | EHC | Encompass Health Corporation | 11.93B | -0.68% | 766,247 | 6.21B |
| 97 | ELAN | Elanco Animal Health Incorporated | 11.77B | -3.84% | 4,935,010 | 5.02B |
| 98 | GMED | Globus Medical, Inc. | 11.50B | -3.02% | 848,028 | 3.14B |
| 99 | ALGN | Align Technology, Inc. | 11.29B | -2.51% | 677,190 | 4.14B |
| 100 | TECH | Bio-Techne Corporation | 11.26B | -0.28% | 3,540,097 | 1.22B |
| 101 | DVA | DaVita Inc. | 11.18B | -1.15% | 483,440 | 14.01B |
| 102 | ABVX | ABIVAX Société Anonyme | 10.95B | -1.96% | 955,525 | 5.67M |
| 103 | GKOS | Glaukos Corporation | 10.90B | -2.46% | 791,868 | 612.84M |
| 104 | AXSM | Axsome Therapeutics, Inc. | 10.90B | -4.66% | 620,926 | 776.57M |
| 105 | CYTK | Cytokinetics, Incorporated | 10.73B | -0.72% | 1,466,146 | 67.67M |
| 106 | ENSG | The Ensign Group, Inc. | 10.39B | -1.45% | 245,064 | 5.49B |
| 107 | RDY | Dr. Reddy's Laboratories Limited | 10.28B | - | 2,552,066 | 3.50B |
| 108 | MOH | Molina Healthcare, Inc. | 10.26B | -2.10% | 553,752 | 42.47B |
| 109 | UHS | Universal Health Services, Inc. | 10.19B | 0.31% | 555,520 | 18.11B |
| 110 | PODD | Insulet Corporation | 10.19B | -3.06% | 1,212,715 | 3.05B |
| 111 | PRAX | Praxis Precision Medicines, Inc. | 10.18B | -5.60% | 496,667 | 7.46M |
| 112 | RGEN | Repligen Corporation | 10.17B | 2.23% | 1,451,479 | 785.10M |
| 113 | APGE | Apogee Therapeutics, Inc. | 10.16B | 0.03% | 1,067,476 | - |
| 114 | KYMR | Kymera Therapeutics, Inc. | 10.10B | -4.56% | 580,745 | 105.00M |
| 115 | BIO | Bio-Rad Laboratories, Inc. | 10.07B | 3.35% | 337,556 | 2.59B |
| 116 | KRYS | Krystal Biotech, Inc. | 9.98B | -1.84% | 196,703 | 440.48M |
| 117 | SMMT | Summit Therapeutics Inc. | 9.92B | -5.19% | 6,568,692 | - |
| 118 | HSIC | Henry Schein, Inc. | 9.86B | -0.93% | 865,705 | 13.60B |
| 119 | IONS | Ionis Pharmaceuticals, Inc. | 9.76B | -3.36% | 2,124,841 | 874.09M |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 9.75B | -2.74% | 412,764 | 281.99M |
| 121 | OSCR | Oscar Health, Inc. | 9.73B | -2.26% | 6,866,743 | 15.32B |
| 122 | AVTR | Avantor, Inc. | 9.64B | 2.08% | 7,130,635 | 6.56B |
| 123 | SYRE | Spyre Therapeutics, Inc. | 9.50B | -1.04% | 598,045 | - |
| 124 | QGEN | Qiagen N.V. | 9.29B | 0.90% | 4,797,653 | 2.10B |
| 125 | IMVT | Immunovant, Inc. | 9.16B | -1.36% | 954,415 | - |
| 126 | BRKR | Bruker Corporation | 9.13B | 2.17% | 1,414,820 | 3.50B |
| 127 | PCVX | Vaxcyte, Inc. | 9.13B | -3.10% | 726,376 | - |
| 128 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.98B | - | 9,002,344 | 42.16M |
| 129 | HQY | HealthEquity, Inc. | 8.72B | 0.31% | 789,725 | 1.34B |
| 130 | TWST | Twist Bioscience Corporation | 8.55B | -4.26% | 2,397,373 | 431.80M |
| 131 | ATR | AptarGroup, Inc. | 8.45B | 0.02% | 420,886 | 3.93B |
| 132 | TXG | 10x Genomics, Inc. | 8.32B | 2.70% | 3,230,166 | 616.91M |
| 133 | IBRX | ImmunityBio, Inc. | 8.31B | -3.57% | 8,099,182 | 165.79M |
| 134 | ALKS | Alkermes plc | 8.06B | -4.30% | 1,635,207 | 1.67B |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.50B | -5.88% | 568,578 | 239.92M |
| 136 | HIMS | Hims & Hers Health, Inc. | 7.43B | 2.48% | 18,929,600 | 2.58B |
| 137 | TGTX | TG Therapeutics, Inc. | 7.17B | -2.19% | 2,153,746 | 799.54M |
| 138 | GRFS | Grifols, S.A. | 7.03B | -3.15% | 293,615 | 8.48B |
| 139 | CHE | Chemed Corporation | 6.96B | -0.15% | 115,465 | 2.60B |
| 140 | CAI | Caris Life Sciences, Inc. | 6.95B | 8.00% | 6,033,171 | 989.61M |
| 141 | ORKA | Oruka Therapeutics, Inc. | 6.94B | -4.40% | 779,262 | - |
| 142 | HNGE | Hinge Health, Inc. | 6.91B | -3.21% | 1,252,827 | 720.06M |
| 143 | PACS | PACS Group, Inc. | 6.90B | -1.54% | 807,788 | 5.55B |
| 144 | CGON | CG Oncology, Inc. | 6.88B | -3.81% | 666,690 | 6.23M |
| 145 | SRRK | Scholar Rock Holding Corporation | 6.73B | -2.23% | 1,534,089 | - |
| 146 | LNTH | Lantheus Holdings, Inc. | 6.54B | -0.24% | 2,139,379 | 1.56B |
| 147 | BLTE | Belite Bio, Inc | 6.52B | -3.92% | 167,322 | - |
| 148 | LQDA | Liquidia Corporation | 6.36B | -5.68% | 1,583,468 | 450.91M |
| 149 | MIRM | Mirum Pharmaceuticals, Inc. | 6.30B | -5.06% | 251,253 | 618.07M |
| 150 | BLCO | Bausch + Lomb Corporation | 6.14B | -1.43% | 411,809 | 5.32B |
| 151 | COGT | Cogent Biosciences, Inc. | 6.13B | -4.18% | 1,934,423 | - |
| 152 | DNTH | Dianthus Therapeutics, Inc. | 6.13B | -3.69% | 734,742 | 1.90M |
| 153 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.12B | -2.88% | 546,876 | 840.85M |
| 154 | STVN | Stevanato Group S.p.A. | 6.10B | 2.95% | 384,376 | 1.40B |
| 155 | DFTX | Definium Therapeutics, Inc. | 6.10B | -0.92% | 1,658,198 | - |
| 156 | TVTX | Travere Therapeutics, Inc. | 6.08B | -2.27% | 875,860 | 591.33M |
| 157 | RDNT | RadNet, Inc. | 6.06B | 2.00% | 366,490 | 2.27B |
| 158 | ERAS | Erasca, Inc. | 5.97B | -5.48% | 1,944,939 | - |
| 159 | PTCT | PTC Therapeutics, Inc. | 5.89B | -4.28% | 802,507 | 1.01B |
| 160 | XENE | Xenon Pharmaceuticals Inc. | 5.78B | -4.16% | 627,184 | 7.50M |
| 161 | LGND | Ligand Pharmaceuticals Incorporated | 5.73B | -1.14% | 107,785 | 290.54M |
| 162 | TFX | Teleflex Incorporated | 5.72B | -0.66% | 297,101 | 2.25B |
| 163 | AMRX | Amneal Pharmaceuticals, Inc. | 5.72B | -1.16% | 1,249,784 | 3.12B |
| 164 | MMED | MiniMed Group, Inc. | 5.67B | -0.20% | 1,424,528 | 3.10B |
| 165 | CRSP | CRISPR Therapeutics AG | 5.62B | -2.83% | 2,896,353 | 13.39M |
| 166 | SHC | Sotera Health Company | 5.48B | 1.16% | 3,308,458 | 1.22B |
| 167 | MMSI | Merit Medical Systems, Inc. | 5.39B | -1.86% | 833,653 | 1.58B |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.00B | -3.87% | 1,318,712 | 1.14B |
| 169 | HAE | Haemonetics Corporation | 4.92B | -0.18% | 891,221 | 1.35B |
| 170 | PBLS | Parabilis Medicines, Inc. | 4.89B | -4.21% | 185,816 | 148.00K |
| 171 | DYN | Dyne Therapeutics, Inc. | 4.85B | -2.99% | 1,478,731 | - |
| 172 | LFST | LifeStance Health Group, Inc. | 4.83B | -1.40% | 2,312,711 | 1.58B |
| 173 | WAY | Waystar Holding Corp. | 4.76B | - | 1,238,141 | 1.21B |
| 174 | EWTX | Edgewise Therapeutics, Inc. | 4.70B | -6.78% | 1,335,632 | - |
| 175 | DOCS | Doximity, Inc. | 4.62B | 0.74% | 2,562,631 | 655.57M |
| 176 | ICUI | ICU Medical, Inc. | 4.56B | -2.53% | 216,490 | 2.16B |
| 177 | BLLN | BillionToOne, Inc. | 4.50B | 3.93% | 621,663 | 397.41M |
| 178 | INDV | Indivior Pharmaceuticals, Inc. | 4.46B | -3.23% | 1,099,276 | 1.33B |
| 179 | CON | Concentra Group Holdings Parent, Inc. | 4.44B | 0.30% | 616,494 | 2.29B |
| 180 | CELC | Celcuity Inc. | 4.43B | -3.29% | 933,121 | - |
| 181 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.42B | 2.75% | 8,540,807 | -665.00K |
| 182 | MANE | Veradermics, Incorporated | 4.40B | -5.31% | 773,146 | - |
| 183 | NVST | Envista Holdings Corporation | 4.33B | -2.36% | 1,915,878 | 2.86B |
| 184 | ELVN | Enliven Therapeutics, Inc. | 4.32B | -0.79% | 841,184 | - |
| 185 | RLAY | Relay Therapeutics, Inc. | 4.32B | -5.01% | 2,731,013 | 10.35M |
| 186 | LIVN | LivaNova PLC | 4.31B | -3.25% | 328,268 | 1.47B |
| 187 | ITGR | Integer Holdings Corporation | 4.26B | -0.07% | 964,102 | 1.84B |
| 188 | IRTC | iRhythm Holdings, Inc. | 4.22B | 2.59% | 610,719 | 825.34M |
| 189 | TLX | Telix Pharmaceuticals Limited | 4.20B | 2.48% | 368,499 | 890.79M |
| 190 | LEGN | Legend Biotech Corporation | 4.12B | -5.93% | 2,768,584 | 1.27B |
| 191 | IOVA | Iovance Biotherapeutics, Inc. | 4.07B | 12.52% | 43,812,294 | 324.97M |
| 192 | HTFL | HeartFlow, Inc. | 4.07B | 2.79% | 1,991,084 | 212.07M |
| 193 | ADPT | Adaptive Biotechnologies Corporation | 4.06B | -0.20% | 1,966,209 | 308.08M |
| 194 | VKTX | Viking Therapeutics, Inc. | 4.01B | -4.50% | 1,670,687 | - |
| 195 | DNLI | Denali Therapeutics Inc. | 3.99B | -2.88% | 974,399 | 3.60M |
| 196 | TNGX | Tango Therapeutics, Inc. | 3.96B | -6.71% | 2,064,995 | 53.81M |
| 197 | IDYA | IDEAYA Biosciences, Inc. | 3.77B | 0.62% | 1,634,020 | 234.13M |
| 198 | RCUS | Arcus Biosciences, Inc. | 3.76B | -2.73% | 1,546,248 | 117.00M |
| 199 | ABCL | AbCellera Biologics Inc. | 3.75B | -3.66% | 6,181,576 | 66.17M |
| 200 | NHC | National HealthCare Corporation | 3.71B | 1.16% | 114,464 | 1.56B |
| 201 | OGN | Organon & Co. | 3.61B | 0.07% | 4,045,020 | 6.13B |
| 202 | GPCR | Structure Therapeutics Inc. | 3.60B | -6.67% | 767,623 | - |
| 203 | OPCH | Option Care Health, Inc. | 3.52B | 0.60% | 1,466,862 | 5.69B |
| 204 | GRAL | GRAIL, Inc. | 3.48B | 5.42% | 1,349,619 | 165.26M |
| 205 | PLSE | Pulse Biosciences, Inc. | 3.41B | 1.77% | 204,244 | 1.19M |
| 206 | WRBY | Warby Parker Inc. | 3.39B | -3.65% | 3,046,029 | 911.61M |
| 207 | QURE | uniQure N.V. | 3.39B | 0.27% | 1,200,811 | 18.67M |
| 208 | VCYT | Veracyte, Inc. | 3.36B | -0.95% | 980,364 | 561.90M |
| 209 | NAMS | NewAmsterdam Pharma Company N.V. | 3.32B | -2.63% | 744,359 | 7.12M |
| 210 | MBX | MBX Biosciences, Inc. | 3.20B | -3.00% | 422,510 | - |
| 211 | IMNM | Immunome, Inc. | 3.19B | -5.85% | 1,025,436 | 4.02M |
| 212 | ARQT | Arcutis Biotherapeutics, Inc. | 3.19B | -4.20% | 2,963,189 | 463.98M |
| 213 | TMDX | TransMedics Group, Inc. | 3.15B | -3.32% | 589,599 | 668.47M |
| 214 | TARS | Tarsus Pharmaceuticals, Inc. | 3.14B | -2.66% | 422,639 | 606.33M |
| 215 | CLDX | Celldex Therapeutics, Inc. | 3.14B | -4.22% | 1,000,606 | 158.00K |
| 216 | IRON | Disc Medicine, Inc. | 3.03B | -1.84% | 333,631 | - |
| 217 | ALMS | Alumis Inc. | 2.96B | -4.71% | 821,032 | 7.40M |
| 218 | ZLAB | Zai Lab Limited | 2.92B | -2.62% | 1,386,065 | 449.61M |
| 219 | BEAM | Beam Therapeutics Inc. | 2.84B | -2.34% | 2,409,389 | 156.04M |
| 220 | AVAH | Aveanna Healthcare Holdings Inc. | 2.83B | -1.44% | 3,286,281 | 2.60B |
| 221 | BKD | Brookdale Senior Living Inc. | 2.82B | -2.56% | 3,854,660 | 2.93B |
| 222 | NRIX | Nurix Therapeutics, Inc. | 2.81B | -2.66% | 811,262 | 36.77M |
| 223 | VRDN | Viridian Therapeutics, Inc. | 2.78B | -1.21% | 1,076,192 | 71.13M |
| 224 | SUPN | Supernus Pharmaceuticals, Inc. | 2.76B | -2.25% | 553,966 | 830.44M |
| 225 | ATAI | AtaiBeckley Inc. | 2.75B | 0.82% | 9,223,993 | 4.47M |
| 226 | PRVA | Privia Health Group, Inc. | 2.71B | -1.35% | 766,495 | 2.36B |
| 227 | SLS | SELLAS Life Sciences Group, Inc. | 2.71B | -3.25% | 7,818,953 | - |
| 228 | RGC | Regencell Bioscience Holdings Limited | 2.70B | -6.37% | 140,918 | - |
| 229 | ALHC | Alignment Healthcare, Inc. | 2.68B | 1.17% | 3,460,813 | 4.58B |
| 230 | PGEN | Precigen, Inc. | 2.66B | 3.91% | 7,838,247 | 85.72M |
| 231 | TRVI | Trevi Therapeutics, Inc. | 2.60B | -2.98% | 1,249,745 | - |
| 232 | NEOG | Neogen Corporation | 2.58B | -2.63% | 1,366,732 | 870.40M |
| 233 | PHVS | Pharvaris N.V. | 2.55B | 0.33% | 571,229 | - |
| 234 | BHC | Bausch Health Companies Inc. | 2.55B | -1.16% | 1,933,230 | 10.85B |
| 235 | NKTR | Nektar Therapeutics | 2.54B | -2.04% | 438,565 | 54.59M |
| 236 | ACHC | Acadia Healthcare Company, Inc. | 2.51B | -1.43% | 1,000,893 | 3.37B |
| 237 | KOD | Kodiak Sciences Inc. | 2.50B | -0.57% | 486,645 | - |
| 238 | AXGN | Axogen, Inc. | 2.50B | -5.09% | 898,323 | 251.17M |
| 239 | RARE | Ultragenyx Pharmaceutical Inc. | 2.49B | -3.51% | 3,257,195 | 717.00M |
| 240 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.47B | -4.07% | 1,765,491 | 940.61M |
| 241 | WGS | GeneDx Holdings Corp. | 2.46B | 3.64% | 453,347 | 454.43M |
| 242 | BFLY | Butterfly Network, Inc. | 2.44B | - | 4,218,397 | 112.14M |
| 243 | OCUL | Ocular Therapeutix, Inc. | 2.44B | -5.46% | 2,716,226 | 52.06M |
| 244 | CDNA | CareDx, Inc. | 2.43B | 1.03% | 911,105 | 458.09M |
| 245 | ATRC | AtriCure, Inc. | 2.42B | -0.25% | 850,581 | 569.62M |
| 246 | ALMR | Alamar Biosciences, Inc. | 2.40B | -2.53% | 243,767 | 100.42M |
| 247 | NUVB | Nuvation Bio Inc. | 2.40B | -5.92% | 5,312,516 | 169.90M |
| 248 | PBH | Prestige Consumer Healthcare Inc. | 2.39B | -2.24% | 336,813 | 1.10B |
| 249 | GRDN | Guardian Pharmacy Services, Inc. | 2.37B | -1.29% | 214,912 | 1.46B |
| 250 | UFPT | UFP Technologies, Inc. | 2.36B | -2.75% | 160,227 | 631.64M |
| 251 | MESO | Mesoblast Limited | 2.32B | 1.75% | 273,585 | 65.38M |
| 252 | AUPH | Aurinia Pharmaceuticals Inc. | 2.30B | 6.80% | 2,637,100 | 311.51M |
| 253 | RAPP | Rapport Therapeutics, Inc. | 2.30B | -2.49% | 174,035 | 20.00M |
| 254 | URGN | UroGen Pharma Ltd. | 2.29B | -6.94% | 1,122,509 | 188.73M |
| 255 | MLYS | Mineralys Therapeutics, Inc. | 2.28B | -4.45% | 606,288 | - |
| 256 | KLRA | Kailera Therapeutics, Inc. | 2.26B | -4.69% | 474,789 | - |
| 257 | VERA | Vera Therapeutics, Inc. | 2.25B | -3.16% | 1,564,053 | - |
| 258 | COAG | Hemab Therapeutics Holdings, Inc. | 2.25B | -6.70% | 398,252 | - |
| 259 | HRMY | Harmony Biosciences Holdings, Inc. | 2.22B | -4.66% | 696,099 | 959.90M |
| 260 | NBTX | Nanobiotix S.A. | 2.22B | -3.77% | 117,724 | 38.27M |
| 261 | ADUS | Addus HomeCare Corporation | 2.21B | 0.44% | 185,225 | 1.48B |
| 262 | ADMA | ADMA Biologics, Inc. | 2.19B | -2.89% | 2,192,501 | 512.28M |
| 263 | CLOV | Clover Health Investments, Corp. | 2.18B | -2.84% | 2,902,385 | 2.48B |
| 264 | HCM | HUTCHMED (China) Limited | 2.16B | -0.24% | 36,092 | 549.12M |
| 265 | VCEL | Vericel Corporation | 2.16B | -3.35% | 413,271 | 306.30M |
| 266 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.15B | 14.82% | 13,145,898 | 208.78M |
| 267 | XRAY | DENTSPLY SIRONA Inc. | 2.15B | -2.27% | 3,472,657 | 3.64B |
| 268 | ESTA | Establishment Labs Holdings Inc. | 2.13B | -5.10% | 461,058 | 245.82M |
| 269 | NEO | NeoGenomics, Inc. | 2.12B | -0.75% | 2,748,216 | 766.30M |
| 270 | MD | Pediatrix Medical Group, Inc. | 2.08B | - | 869,775 | 1.95B |
| 271 | NVCR | NovoCure Limited | 2.07B | -2.36% | 955,638 | 699.19M |
| 272 | ZBIO | Zenas BioPharma, Inc. | 2.06B | 1.18% | 1,172,562 | 1.00M |
| 273 | PVLA | Palvella Therapeutics, Inc. | 2.05B | -4.92% | 176,193 | - |
| 274 | GENB | Generate Biomedicines, Inc. | 2.05B | -5.77% | 952,700 | 26.48M |
| 275 | BHVN | Biohaven Ltd. | 2.04B | -4.53% | 4,017,422 | - |
| 276 | SRPT | Sarepta Therapeutics, Inc. | 2.03B | -2.58% | 1,832,136 | 1.97B |
| 277 | STOK | Stoke Therapeutics, Inc. | 2.03B | -4.93% | 812,001 | 27.59M |
| 278 | AGIO | Agios Pharmaceuticals, Inc. | 2.01B | -4.24% | 697,493 | 98.34M |
| 279 | XNCR | Xencor, Inc. | 2.01B | -1.89% | 1,655,225 | 104.97M |
| 280 | PGNY | Progyny, Inc. | 1.99B | 1.68% | 1,141,774 | 1.31B |
| 281 | TSHA | Taysha Gene Therapies, Inc. | 1.99B | -4.98% | 1,567,725 | 5.49M |
| 282 | ASTH | Astrana Health, Inc. | 1.98B | -1.68% | 214,310 | 3.84B |
| 283 | TRLV | Trulieve Cannabis Corp. | 1.97B | 1.59% | 1,258,109 | 1.14B |
| 284 | GHRS | GH Research PLC | 1.97B | -3.76% | 148,529 | - |
| 285 | FBRX | Forte Biosciences, Inc. | 1.94B | -0.01% | 3,195,174 | - |
| 286 | CMPS | COMPASS Pathways plc | 1.91B | -1.36% | 2,034,471 | - |
| 287 | SEPN | Septerna, Inc. | 1.90B | -7.15% | 430,003 | 98.88M |
| 288 | PRGO | Perrigo Company plc | 1.90B | -1.86% | 2,370,442 | 4.14B |
| 289 | KARD | Kardigan, Inc. | 1.89B | -7.95% | 258,407 | - |
| 290 | ZYME | Zymeworks Inc. | 1.89B | -2.35% | 498,602 | 37.13M |
| 291 | LMAT | LeMaitre Vascular, Inc. | 1.88B | -1.55% | 269,456 | 262.43M |
| 292 | DMRA | Damora Therapeutics, Inc. | 1.87B | -6.57% | 169,078 | - |
| 293 | IMCR | Immunocore Holdings plc | 1.87B | -1.57% | 590,251 | 430.78M |
| 294 | LKFT | Lakefront Biotherapeutics NV | 1.87B | -3.71% | 244,325 | 1.13B |
| 295 | SNDA | Sonida Senior Living, Inc. | 1.86B | -3.28% | 390,191 | 481.07M |
| 296 | SGRY | Surgery Partners, Inc. | 1.81B | 2.50% | 6,498,313 | 3.37B |
| 297 | BLFS | BioLife Solutions, Inc. | 1.81B | 1.37% | 681,727 | 106.69M |
| 298 | PSNL | Personalis, Inc. | 1.80B | 6.77% | 14,300,308 | 69.67M |
| 299 | RXRX | Recursion Pharmaceuticals, Inc. | 1.79B | -4.57% | 21,453,650 | 54.86M |
| 300 | INSP | Inspire Medical Systems, Inc. | 1.77B | -0.68% | 474,862 | 898.74M |
| 301 | SNDX | Syndax Pharmaceuticals, Inc. | 1.76B | -4.91% | 904,111 | 252.25M |
| 302 | BRVE | Braveheart Bio, Inc. | 1.76B | -5.35% | 166,726 | - |
| 303 | NTLA | Intellia Therapeutics, Inc. | 1.74B | -6.33% | 4,703,599 | 59.51M |
| 304 | FTRE | Fortrea Holdings Inc. | 1.73B | 0.28% | 1,516,157 | 2.68B |
| 305 | ETON | Eton Pharmaceuticals, Inc. | 1.71B | -2.55% | 581,901 | 105.60M |
| 306 | ANAB | AnaptysBio, Inc. | 1.68B | -4.34% | 327,134 | 232.39M |
| 307 | ANIP | ANI Pharmaceuticals, Inc. | 1.66B | -0.90% | 252,403 | 978.38M |
| 308 | AVLN | Avalyn Pharma Inc. | 1.65B | -4.72% | 159,821 | - |
| 309 | OMCL | Omnicell, Inc. | 1.62B | -2.55% | 471,479 | 1.25B |
| 310 | BCAX | Bicara Therapeutics Inc. | 1.61B | -5.68% | 448,986 | - |
| 311 | MAZE | Maze Therapeutics, Inc. | 1.61B | -2.76% | 247,667 | 20.00M |
| 312 | AZTA | Azenta, Inc. | 1.60B | 2.50% | 706,897 | 613.81M |
| 313 | KMTS | Kestra Medical Technologies, Ltd. | 1.60B | -2.33% | 246,907 | 95.13M |
| 314 | ABSI | Absci Corporation | 1.59B | -7.11% | 2,909,322 | 1.56M |
| 315 | HCSG | Healthcare Services Group, Inc. | 1.58B | 0.31% | 747,230 | 1.86B |
| 316 | HROW | Harrow, Inc. | 1.58B | 1.01% | 450,074 | 275.59M |
| 317 | AAPG | Ascentage Pharma Group International | 1.58B | -3.94% | 12,061 | 94.61M |
| 318 | TNDM | Tandem Diabetes Care, Inc. | 1.57B | -3.79% | 1,821,158 | 1.04B |
| 319 | XERS | Xeris Biopharma Holdings, Inc. | 1.57B | -2.05% | 2,001,181 | 335.41M |
| 320 | VIR | Vir Biotechnology, Inc. | 1.56B | -5.73% | 1,060,645 | 303.23M |
| 321 | AGL | agilon health, inc. | 1.56B | -0.97% | 190,299 | 5.92B |
| 322 | SLBT | SL Science Holding Limited | 1.55B | 1.50% | 79,031 | 3.27M |
| 323 | CNMD | CONMED Corporation | 1.54B | 0.25% | 246,444 | 1.37B |
| 324 | TYRA | Tyra Biosciences, Inc. | 1.53B | -4.18% | 218,345 | - |
| 325 | FRNM | Freenome, Inc. | 1.52B | -0.88% | 877,732 | 34.24M |
| 326 | ALVO | Alvotech | 1.52B | 7.02% | 1,370,569 | 494.61M |
| 327 | LBRX | LB Pharmaceuticals Inc | 1.52B | -3.49% | 169,333 | - |
| 328 | INVA | Innoviva, Inc. | 1.52B | -2.23% | 461,612 | 440.00M |
| 329 | ENOV | Enovis Corporation | 1.51B | -1.21% | 657,559 | 2.30B |
| 330 | TRAX | First Tracks Biotherapeutics, Inc. | 1.50B | -7.91% | 478,170 | - |
| 331 | ARDT | Ardent Health, Inc. | 1.48B | -1.32% | 237,646 | 6.41B |
| 332 | SDGR | Schrödinger, Inc. | 1.46B | -1.36% | 1,033,966 | 259.04M |
| 333 | INBX | Inhibrx Biosciences, Inc. | 1.46B | -2.30% | 210,607 | 1.30M |
| 334 | INNV | InnovAge Holding Corp. | 1.46B | -2.01% | 124,267 | 949.17M |
| 335 | OMDA | Omada Health, Inc. | 1.45B | -3.11% | 640,586 | 309.76M |
| 336 | AVBP | ArriVent BioPharma, Inc. | 1.44B | -2.80% | 406,273 | - |
| 337 | ORIC | ORIC Pharmaceuticals, Inc. | 1.44B | -5.26% | 927,994 | - |
| 338 | ATEC | Alphatec Holdings, Inc. | 1.43B | -4.72% | 1,150,330 | 815.05M |
| 339 | PAHC | Phibro Animal Health Corporation | 1.43B | -0.73% | 179,207 | 1.50B |
| 340 | MGTX | MeiraGTx Holdings plc | 1.40B | -2.87% | 861,869 | 397.50M |
| 341 | SVRA | Savara Inc. | 1.40B | -1.61% | 2,541,801 | - |
| 342 | NVAX | Novavax, Inc. | 1.39B | -4.21% | 5,976,487 | 413.80M |
| 343 | CGEM | Cullinan Therapeutics, Inc. | 1.38B | -5.06% | 690,106 | - |
| 344 | MNKD | MannKind Corporation | 1.37B | -3.07% | 3,415,966 | 393.63M |
| 345 | VOR | Vor Biopharma Inc. | 1.36B | -2.18% | 544,377 | - |
| 346 | AORT | Artivion, Inc. | 1.36B | -2.91% | 819,357 | 471.47M |
| 347 | PNTG | The Pennant Group, Inc. | 1.36B | -0.36% | 161,366 | 1.10B |
| 348 | LTGO | Latigo Biotherapeutics, Inc. | 1.35B | 2.20% | 72,515 | - |
| 349 | MLTX | MoonLake Immunotherapeutics | 1.35B | -5.20% | 1,367,763 | - |
| 350 | JBIO | Jade Biosciences, Inc. | 1.35B | -5.85% | 820,175 | - |
| 351 | OMER | Omeros Corporation | 1.35B | 1.31% | 1,649,198 | 38.42M |
| 352 | AMN | AMN Healthcare Services, Inc. | 1.35B | -1.50% | 406,069 | 3.43B |
| 353 | ANRO | Alto Neuroscience, Inc. | 1.34B | -1.83% | 313,918 | - |
| 354 | AKTS | Aktis Oncology, Inc. | 1.33B | -4.08% | 253,619 | 10.06M |
| 355 | CERT | Certara, Inc. | 1.33B | 4.43% | 2,699,214 | 421.75M |
| 356 | DRTS | Alpha Tau Medical Ltd. | 1.33B | -0.76% | 343,989 | - |
| 357 | REPL | Replimune Group, Inc. | 1.32B | -5.13% | 3,999,481 | - |
| 358 | NUTX | Nutex Health Inc. | 1.29B | -1.09% | 84,656 | 846.72M |
| 359 | IART | Integra LifeSciences Holdings Corporation | 1.29B | -3.77% | 473,311 | 1.65B |
| 360 | SPTX | Seaport Therapeutics, Inc. | 1.29B | -1.58% | 76,987 | - |
| 361 | GLUE | Monte Rosa Therapeutics, Inc. | 1.26B | -6.28% | 1,021,608 | 28.73M |
| 362 | GDRX | GoodRx Holdings, Inc. | 1.21B | 0.56% | 2,718,274 | 785.23M |
| 363 | CRVS | Corvus Pharmaceuticals, Inc. | 1.21B | -6.95% | 781,631 | - |
| 364 | BVS | Bioventus Inc. | 1.21B | -2.38% | 616,441 | 581.85M |
| 365 | CRON | Cronos Group Inc. | 1.19B | -2.13% | 972,155 | 179.09M |
| 366 | PRCT | PROCEPT BioRobotics Corporation | 1.19B | -5.39% | 1,155,436 | 337.34M |
| 367 | ODTX | Odyssey Therapeutics, Inc. | 1.18B | 1.73% | 112,482 | 99.00K |
| 368 | TDOC | Teladoc Health, Inc. | 1.18B | -2.55% | 3,022,974 | 2.49B |
| 369 | IMTX | Immatics N.V. | 1.17B | -7.57% | 436,100 | 47.65M |
| 370 | USPH | U.S. Physical Therapy, Inc. | 1.16B | -1.53% | 132,040 | 804.27M |
| 371 | STAA | STAAR Surgical Company | 1.16B | -6.45% | 813,276 | 339.59M |
| 372 | APMD | Apnimed, Inc. | 1.14B | -10.86% | 433,782 | 120.15M |
| 373 | LMRI | Lumexa Imaging Holdings, Inc. | 1.12B | -1.43% | 1,153,387 | 1.04B |
| 374 | SANA | Sana Biotechnology, Inc. | 1.12B | -8.78% | 2,745,511 | - |
| 375 | IRMD | IRADIMED CORPORATION | 1.11B | -0.82% | 69,026 | 86.34M |
| 376 | GMRS | GMR Solutions Inc. | 1.10B | -1.94% | 914,392 | 5.88B |
| 377 | IVA | Inventiva S.A. | 1.09B | -2.31% | 517,338 | 7.94M |
| 378 | OPK | OPKO Health, Inc. | 1.09B | - | 2,264,429 | 587.90M |
| 379 | AVTX | Avalo Therapeutics, Inc. | 1.06B | -4.48% | 559,827 | 59.00K |
| 380 | JANX | Janux Therapeutics, Inc. | 1.06B | -1.37% | 1,121,802 | 24.00M |
| 381 | KURA | Kura Oncology, Inc. | 1.04B | -6.54% | 2,134,396 | 77.23M |
| 382 | WVE | Wave Life Sciences, Inc. | 1.03B | -3.05% | 2,660,513 | 65.37M |
| 383 | QDEL | QuidelOrtho Corporation | 1.02B | 7.61% | 2,508,016 | 2.67B |
| 384 | CSTL | Castle Biosciences, Inc. | 1.01B | 1.89% | 279,221 | 357.28M |
| 385 | GERN | Geron Corporation | 995.83M | -2.52% | 5,101,854 | 204.56M |
| 386 | ANNX | Annexon, Inc. | 982.02M | -5.82% | 1,670,075 | - |
| 387 | CLYM | Climb Bio, Inc. | 977.57M | -1.85% | 784,924 | - |
| 388 | SLDB | Solid Biosciences Inc. | 975.75M | -6.57% | 1,076,892 | - |
| 389 | DSGN | Design Therapeutics, Inc. | 973.77M | -2.38% | 508,992 | - |
| 390 | ARDX | Ardelyx, Inc. | 971.83M | -3.23% | 4,565,257 | 450.89M |
| 391 | LXRX | Lexicon Pharmaceuticals, Inc. | 970.00M | -9.54% | 4,746,460 | 41.47M |
| 392 | OLMA | Olema Pharmaceuticals, Inc. | 953.72M | -3.63% | 1,039,089 | - |
| 393 | PCRX | Pacira BioSciences, Inc. | 949.91M | -2.18% | 289,495 | 746.16M |
| 394 | CADL | Candel Therapeutics, Inc. | 945.00M | -8.52% | 1,541,934 | - |
| 395 | ABUS | Arbutus Biopharma Corporation | 943.73M | -4.22% | 1,070,330 | 181.72M |
| 396 | IMMX | Immix Biopharma, Inc. | 941.46M | -0.23% | 1,666,194 | - |
| 397 | CBLL | CeriBell, Inc. | 932.97M | -2.33% | 218,073 | 101.96M |
| 398 | ACRS | Aclaris Therapeutics, Inc. | 931.77M | -1.71% | 1,514,519 | 8.22M |
| 399 | AMPH | Amphastar Pharmaceuticals, Inc. | 922.22M | -0.28% | 338,697 | 730.02M |
| 400 | AVR | Anteris Technologies Global Corp. | 901.49M | -5.90% | 1,171,489 | 2.24M |
| 401 | COLL | Collegium Pharmaceutical, Inc. | 896.58M | -4.18% | 492,502 | 808.21M |
| 402 | FDMT | 4D Molecular Therapeutics, Inc. | 889.43M | -3.94% | 1,373,745 | 92.01M |
| 403 | ANL | Adlai Nortye Ltd. | 883.54M | -4.26% | 112,494 | 18.06M |
| 404 | TBPH | Theravance Biopharma, Inc. | 880.02M | -0.24% | 172,069 | 104.31M |
| 405 | SGP | SpyGlass Pharma, Inc. | 877.34M | -3.67% | 51,030 | - |
| 406 | BBNX | Beta Bionics, Inc. | 876.40M | -2.65% | 1,834,903 | 119.01M |
| 407 | OBX | Obsidian Therapeutics, Inc. | 874.76M | 0.95% | 74,094 | - |
| 408 | AHG | Akso Health Group | 873.84M | 5.51% | 14,950 | 13.83M |
| 409 | SIBN | SI-BONE, Inc. | 873.07M | -2.16% | 518,038 | 213.60M |
| 410 | ATTO | Attovia Therapeutics, Inc. | 869.62M | -8.72% | 443,759 | 1.35M |
| 411 | DBVT | DBV Technologies S.A. | 861.96M | -3.65% | 113,630 | 5.04M |
| 412 | INMD | InMode Ltd. | 857.61M | -0.80% | 433,200 | 374.63M |
| 413 | GLAS | Glass House Brands Inc. | 853.78M | -1.86% | 206,246 | 177.68M |
| 414 | RIGL | Rigel Pharmaceuticals, Inc. | 845.26M | -3.64% | 197,797 | 276.79M |
| 415 | HSTM | HealthStream, Inc. | 835.97M | 0.14% | 202,565 | 321.12M |
| 416 | FTH | Faeth Therapeutics, Inc. | 829.48M | -3.05% | 293,099 | - |
| 417 | ACHV | Achieve Life Sciences, Inc. | 825.28M | -5.98% | 1,453,855 | - |
| 418 | PHAR | Pharming Group N.V. | 822.85M | -1.43% | 17,914 | 366.48M |
| 419 | OCS | Oculis Holding AG | 811.16M | -3.17% | 111,216 | 1.45M |
| 420 | AURA | Aura Biosciences, Inc. | 805.79M | -0.26% | 544,981 | - |
| 421 | SLN | Silence Therapeutics plc | 792.96M | -3.23% | 585,256 | 615.00K |
| 422 | DRUG | Bright Minds Biosciences Inc. | 783.53M | -7.29% | 116,693 | - |
| 423 | VREX | Varex Imaging Corporation | 779.32M | 0.16% | 739,693 | 865.00M |
| 424 | HELP | Cybin Inc. | 772.94M | 5.86% | 1,821,762 | - |
| 425 | NVCT | Nuvectis Pharma, Inc. | 760.78M | 0.09% | 209,081 | - |
| 426 | NGNE | Neurogene Inc. | 760.23M | -3.65% | 104,306 | 925.00K |
| 427 | GYRE | Gyre Therapeutics, Inc. | 744.36M | -1.82% | 50,327 | 109.82M |
| 428 | MNPR | Monopar Therapeutics Inc. | 744.25M | -10.47% | 208,103 | - |
| 429 | PHR | Phreesia, Inc. | 741.74M | 0.33% | 862,116 | 495.59M |
| 430 | RGNX | REGENXBIO Inc. | 730.11M | -7.99% | 709,207 | 174.48M |
| 431 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 727.98M | -5.42% | 171,113 | - |
| 432 | STTK | Shattuck Labs, Inc. | 727.63M | -5.35% | 339,253 | 1.00M |
| 433 | ALLO | Allogene Therapeutics, Inc. | 725.53M | -5.83% | 4,861,236 | 4.64M |
| 434 | SSII | SS Innovations International, Inc. | 723.39M | 0.28% | 68,934 | 52.40M |
| 435 | AHCO | AdaptHealth Corp. | 719.08M | -4.77% | 2,693,879 | 3.36B |
| 436 | CTMX | CytomX Therapeutics, Inc. | 716.89M | -7.84% | 2,600,551 | 18.30M |
| 437 | SOPH | SOPHiA GENETICS SA | 709.11M | 0.60% | 648,070 | 86.17M |
| 438 | ZVRA | Zevra Therapeutics, Inc. | 706.07M | -1.98% | 924,663 | 136.07M |
| 439 | TECX | Tectonic Therapeutic, Inc. | 704.75M | -2.67% | 196,846 | - |
| 440 | EVO | Evotec SE | 696.71M | -1.01% | 77,309 | 819.47M |
| 441 | CBIO | Crescent Biopharma, Inc. | 694.66M | -6.29% | 124,803 | 11.88M |
| 442 | KIDS | OrthoPediatrics Corp. | 684.86M | -1.02% | 259,617 | 252.72M |
| 443 | IRWD | Ironwood Pharmaceuticals, Inc. | 684.09M | -5.05% | 1,471,075 | 389.32M |
| 444 | PHAT | Phathom Pharmaceuticals, Inc. | 683.10M | -7.73% | 1,405,606 | 239.66M |
| 445 | ASMB | Assembly Biosciences, Inc. | 682.69M | -0.92% | 191,253 | 74.85M |
| 446 | PRLD | Prelude Therapeutics Incorporated | 669.47M | 12.46% | 2,438,670 | 22.42M |
| 447 | STLN | Starling Oncology, Inc. | 666.53M | -1.80% | 1,172,757 | 587.24M |
| 448 | AGMB | AgomAb Therapeutics NV | 661.40M | -2.33% | 90,427 | - |
| 449 | AUTL | Autolus Therapeutics plc | 654.76M | -3.15% | 3,254,202 | 117.39M |
| 450 | ANGO | AngioDynamics, Inc. | 653.88M | -1.56% | 160,688 | 320.17M |
| 451 | VALN | Valneva SE | 648.10M | -0.29% | 30,243 | 163.30M |
| 452 | CRMD | CorMedix Inc. | 641.48M | -3.40% | 1,004,389 | 462.25M |
| 453 | TLRY | Tilray Brands, Inc. | 633.32M | -3.31% | 3,755,263 | 915.45M |
| 454 | SGMT | Sagimet Biosciences Inc. | 632.78M | -3.78% | 977,021 | - |
| 455 | MDXG | MiMedx Group, Inc. | 626.77M | -3.37% | 1,432,575 | 355.17M |
| 456 | OABI | OmniAb, Inc. | 625.18M | 2.63% | 2,253,122 | 38.46M |
| 457 | SCTX | Scribe Therapeutics Inc. | 619.32M | 5.73% | 419,066 | 36.28M |
| 458 | VSTM | Verastem, Inc. | 617.64M | -6.58% | 2,294,170 | 87.53M |
| 459 | BWAY | BrainsWay Ltd. | 609.52M | -1.32% | 53,695 | 60.70M |
| 460 | CTKB | Cytek Biosciences, Inc. | 605.72M | -0.85% | 660,883 | 206.71M |
| 461 | CTNM | Contineum Therapeutics, Inc. | 602.69M | - | 284,244 | - |
| 462 | ARVN | Arvinas, Inc. | 590.11M | -6.77% | 601,731 | 316.70M |
| 463 | WEAV | Weave Communications, Inc. | 583.19M | -0.27% | 6,511,521 | 257.79M |
| 464 | EIKN | Eikon Therapeutics, Inc. | 582.27M | -10.49% | 533,136 | - |
| 465 | DCTH | Delcath Systems, Inc. | 581.20M | -2.33% | 385,430 | 95.42M |
| 466 | CTEV | Claritev Corporation | 577.57M | -3.70% | 94,411 | 994.67M |
| 467 | PRME | Prime Medicine, Inc. | 576.41M | -8.47% | 3,797,851 | 4.07M |
| 468 | ALT | Altimmune, Inc. | 573.83M | -5.45% | 4,681,380 | 31.00K |
| 469 | AQST | Aquestive Therapeutics, Inc. | 564.17M | -2.07% | 2,668,133 | 54.09M |
| 470 | CERS | Cerus Corporation | 562.25M | -2.11% | 2,349,553 | 221.55M |
| 471 | ENTX | Entera Bio Ltd. | 557.52M | 3.54% | 461,379 | 42.00K |
| 472 | EOLS | Evolus, Inc. | 551.52M | -2.91% | 661,691 | 316.49M |
| 473 | ZURA | Zura Bio Limited | 551.02M | -1.54% | 796,867 | - |
| 474 | FLGT | Fulgent Genetics, Inc. | 548.10M | 0.91% | 203,680 | 323.93M |
| 475 | SPRY | ARS Pharmaceuticals, Inc. | 547.46M | -13.71% | 2,114,121 | 116.93M |
| 476 | ARTV | Artiva Biotherapeutics, Inc. | 544.64M | -4.79% | 269,009 | 251.00K |
| 477 | CABA | Cabaletta Bio, Inc. | 540.85M | 2.90% | 5,738,039 | - |
| 478 | OVID | Ovid Therapeutics Inc. | 535.12M | -6.48% | 1,146,456 | 1.58M |
| 479 | EVH | Evolent Health, Inc. | 531.38M | 2.62% | 2,783,917 | 2.10B |
| 480 | TCMD | Tactile Systems Technology, Inc. | 530.74M | -0.72% | 378,505 | 350.31M |
| 481 | SRTA | Strata Critical Medical, Inc. | 527.26M | 1.19% | 1,322,328 | 255.98M |
| 482 | MPLT | MapLight Therapeutics, Inc. | 520.82M | -7.57% | 497,935 | - |
| 483 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 484 | KYTX | Kyverna Therapeutics, Inc. | 502.79M | -8.34% | 835,872 | - |
| 485 | CCCC | C4 Therapeutics, Inc. | 495.79M | -4.28% | 2,111,193 | 35.04M |
| 486 | RLMD | Relmada Therapeutics, Inc. | 494.95M | -3.93% | 1,033,935 | - |
| 487 | EVMN | Evommune, Inc. | 492.48M | -9.59% | 764,803 | 10.00M |
| 488 | RZLT | Rezolute, Inc. | 486.82M | -1.27% | 866,690 | - |
| 489 | BLSM | BlossomHill Therapeutics, Inc. | 484.17M | -2.29% | 212,021 | - |
| 490 | NRC | NRC Health | 482.65M | -0.73% | 136,761 | 140.00M |
| 491 | NPCE | NeuroPace, Inc. | 481.23M | -4.23% | 173,285 | 106.99M |
| 492 | QTTB | Q32 Bio Inc. | 472.14M | 0.13% | 389,476 | 53.74M |
| 493 | OCGN | Ocugen, Inc. | 471.36M | -6.08% | 3,961,826 | 4.58M |
| 494 | PBYI | Puma Biotechnology, Inc. | 470.26M | -4.00% | 390,262 | 231.24M |
| 495 | DNA | Ginkgo Bioworks Holdings, Inc. | 468.69M | -9.73% | 1,420,076 | 132.42M |
| 496 | SENS | Senseonics Holdings, Inc. | 466.35M | -3.18% | 544,621 | 48.55M |
| 497 | EYPT | EyePoint, Inc. | 465.55M | -14.29% | 7,378,200 | 2.79M |
| 498 | PRTA | Prothena Corporation plc | 463.57M | -2.80% | 345,968 | 54.53M |
| 499 | CLPT | ClearPoint Neuro, Inc. | 463.36M | -4.82% | 339,538 | 42.28M |
| 500 | SI | Shoulder Innovations, Inc. | 460.10M | -4.99% | 96,478 | 60.06M |